Abiopharma

News list

Director Khan Najat 🔴 sold 28.3K shares of RECURSION PHARMACEUTICALS, INC. (RXRX) at $3.35 Transaction Date: Mar 09, 2026 | Filing ID: 000048

Full text

News bot March 11, 2026, 9:45 p.m.
🔍 Khan Najat (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 28,298
Detailed Transactions and Holdings:
- Sold 28,298 shares of Class A Common Stock at $3.3451 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,262,085.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025
- F2: This transaction was executed in multiple trades at prices ranging from $3.32 to $3.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.